In order to clarify the role of the purine 2-amino group in the recognition of DNA by small molecules we have examined the binding of actinomycin D and echinomycin to artificial DNA molecules asymmetrically substituted with inosine and/or 2,6-diaminopurine (DAP) in one of the complementary strands. These DNAs, prepared by a method based upon PCR, present various potential sites for antibiotic binding, including several containing only a single purine 2-amino group in different configurations. The results show unambiguously that the presence of two 2-amino groups is mandatory for binding of actinomycin D to doublestranded DNA. In the case of echinomycin only one purine 2-amino group is required for remarkably strong binding to the asymmetric TpDAP·TpA dinucleotide step, but the CpDAP·TpI step (which also contains only a single purine-2 amino group) does not afford a binding site. Evidently, removing a 2-amino group (G→I substitution) is dominant over adding one (A→DAP substitution). No sequences containing just a single guanine residue are acceptable. The possibility is raised that replacing guanosine with inosine may do more than remove a group endowed with hydrogen bonding capability and interfere with ligand binding in other ways. The new methodology developed to construct asymmetrically substituted DNA substrates for this work provides a novel strategy that should be generally applicable for studying ligand-DNA interactions, beyond the specific interest in drug binding to DNA, and may help to elucidate how proteins and oligonucleotides recognize their target sites.
INTRODUCTION
The 2-amino group of guanine has proved to be a critical element in the sequence-selective recognition of DNA via the minor groove of the double helix, where most small molecules bind (1, 2) . Not only does it serve as the sole hydrogen bond donor there but it also affects the local conformation of the helix, providing a basis for 'analogue' as well as 'digital' readout of the nucleotide sequence (3) . The exocyclic amino group represents the only readily accessible sequence information available to molecules binding in the minor groove. Two well-known antibiotics which exploit the 2-amino group of guanine to locate their preferred binding sites on DNA are echinomycin and actinomycin (Fig. 1) .
Echinomycin binds to the minor groove via a mechanism involving bisintercalation of its quinoxaline rings (4) . It recognizes sequences containing the CpG dinucleotide step (5) (6) (7) (8) (9) . In high resolution NMR and X-ray structures of echinomycin-oligonucleotide complexes reported several years ago, the alanine residues of the cyclic depsipeptide ring were seen to form three hydrogen bonds to the guanine bases of the DNA (7) (8) (9) and it has been suggested that the formation of these hydrogen bonds actually underlies the specific recognition of DNA sequences by echinomycin. The antibiotic donates two hydrogen bonds to the guanine N3 atoms present in the CpG step and acts as acceptor for a further hydrogen bond from the 2-amino group of one of the guanine residues (7) (8) (9) . The possible hydrogen bond to the 2-amino of the other guanine residue is not formed, suggesting that only one purine 2-amino group may be required for site recognition. However, echinomycin failed to bind to a short synthetic inosinecontaining polynucleotide which could only offer CpG·CpI dinucleotide steps, where only one purine 2-amino group is present, seemingly contradicting that idea (10) . More recently, while the present work was in progress, high resolution NMR structures were reported for complexes between oligonucleotides and several other antibiotics closely related to echinomycin (11) (12) (13) (14) . They revealed the formation of paired hydrogen bonds to both guanine bases at the binding site, further highlighting the question of whether site recognition demands two purine 2-amino groups or whether acceptance of a hydrogen bond from just one will do.
Actinomycin D also binds to the DNA minor groove by intercalating its phenoxazone ring system (15, 16) . It recognizes sequences containing GpC steps (16) (17) (18) (19) (20) (21) (22) (23) (24) , although there is some evidence for a secondary interaction with GpG-containing regions (17) (18) (19) 25) . Its specificity also appears to be determined by specific hydrogen bonding of its peptide rings to the guanine nucleotides and in this case strong hydrogen bonds are always formed between both guanine 2-amino groups present in the GpC step and the carbonyl oxygen atoms of the L-threonine residues (16, 20, 26) . Two weaker hydrogen bonds connect the guanine N3 atoms and the NH groups of the same amino acids.
Evidence that the purine 2-amino group really is mandatory for binding site recognition by these antibiotics was obtained by *To whom correspondence should be addressed. Tel: +44 1223 334034; Fax: +44 1223 334040; Email: mjw11@cus.cam.ac.uk footprinting studies performed on DNA fragments containing 2,6-diaminopurine (DAP) in place of adenine, which incidentally revealed that the ligands displayed a definite preference for sequences containing DAP rather than their canonical guaninecontaining sites (27) . DAP resembles adenine with an additional 2-amino group (see Fig. 1 ). In these experiments echinomycin and actinomycin bound almost exclusively to sites containing TpD·TpD and DpT·DpT dinucleotide steps respectively (27) .
Here we have sought to clarify and expand these observations by examining the binding of echinomycin and actinomycin to DNA fragments asymmetrically substituted with inosine and/or DAP, primarily to investigate the interaction with sites presenting only a single purine 2-amino group for hydrogen bonding. We find that for binding of actinomycin to DNA the presence of two purine 2-amino groups is absolutely essential. In contrast, for binding of echinomycin to sites containing DAP only one purine 2-amino group is necessary, provided that the neighbouring base pair does not contain inosine.
MATERIALS AND METHODS

Antibiotics
Echinomycin was obtained from Parke-Davis. It was dissolved at a concentration of 500 µM in methanol to furnish a stock solution from which the working solutions were prepared. Because of the low solubility of echinomycin in water the stock was diluted to the requisite concentration with appropriate volumes of TN buffer (10 mM Tris-HCl, pH 7, 10 mM NaCl) so as to yield a final methanol concentration not exceeding 5% (v/v) in the footprinting reactions. From control experiments, consistent with previous experience (5), it was found that the presence of methanol at such low concentrations has no significant effect on the DNase I digestion reaction. The concentration of echinomycin was determined by measuring the absorbance at 325 nm using a molar extinction coefficient of 11 500 M -1 cm -1 (28) . Actinomycin D (actinomycin C1) was obtained from Boehringer Mannheim. It was dissolved in TN buffer to a stock concentration of 100 µM. Working solutions were prepared by diluting the stock solution with TN buffer. The concentration of actinomycin D was determined by measuring the absorbance at 440 nm using a molar extinction coefficient of 24 800 M -1 cm -1 (16) .
Chemicals and biochemicals
Ammonium persulphate, Tris base, acrylamide, bisacrylamide, ultrapure urea, boric acid, tetramethylethylenediamine and dimethyl sulphate were from BDH. Formic acid, piperidine and formamide were from Aldrich. Fuji X-ray films were used for autoradiography, with other photographic requisites from Kodak. Bromophenol blue and xylene cyanol were from Sigma. Deoxyribonucleoside triphosphates labelled with α-32 P were obtained from NEN DuPont. Restriction endonucleases EcoRI and AvaI (Boehringer), Taq polymerase (Promega), Pfu polymerase (Stratagene), DNase I (Sigma) and AMV reverse transcriptase (Boehringer) were used according to the suppliers' recommended protocols. The primers shown in Figure 2 were obtained from the Laboratory of Molecular Biology, Medical Research Council (Cambridge, UK). All other chemicals were analytical grade reagents and all solutions were prepared using doubly deionised Millipore filtered water.
Polymerase chain reactions
For the synthesis of DNA fragments containing natural nucleotides we used the Pfu DNA polymerase. For the synthesis of DNA fragments substituted with inosine or DAP we employed Taq DNA polymerase, which has little or no 'proof-reading' capacity and will accept unnatural nucleoside triphosphates. The PCR reaction mixtures contained 10 ng tyrT template, 1 µM each appropriate primer and 250 µM each nucleotide. The different DNA polymerases were chosen solely on the basis of their preferences for the nucleotides used in the PCR reaction. For 50 µl PCR mixtures containing natural nucleotides, we used 0.5 U Pfu DNA polymerase. In reactions containing inosine, 1 U Taq DNA polymerase was used in a 50 µl volume. For PCR reactions containing DAP or DAP and inosine, 5 U Taq DNA polymerase were used in a 50 µl mixture. The PCR mixtures were buffered with commercially supplied solutions. In order to prevent non-specific primer annealing the tubes were heated to 60_C prior to addition of the appropriate DNA polymerase. Then to each PCR reaction ∼60 µl mineral oil was added in order to prevent evaporation. The samples containing natural nucleotides or DAP were heated to 94_C for 3 min. Following this initial denaturation step, 20 amplification cycles were performed, each consisting of 94_C denaturation for 1 min, 37_C primer annealing for 2 min and polymerization at 72_C for 10 min. After completing the last amplification cycle, the PCR samples were heated to 72_C for another 10 min to complete unfinished polynucleotide chains. Following this step the reaction mixtures were slowly cooled to facilitate complete annealing of complementary DNA strands, including two additional 5 min steps, one at 55_C and one at 37_C. PCRs containing inosine or inosine plus DAP were conducted at lower temperature because of the lower thermal stability of inosine-containing DNA. The PCR programme consisted in this case of an 84_C denaturing step, 30_C primer annealing step and 62_C polymerization step. The number of cycles and cycling time as well as the last two annealing steps were identical to the PCR programme used for natural nucleotides. After the programme was complete the mineral oil was removed by extracting the reaction mixtures with chloroform. Parallel reactions were then pooled and, if necessary, the volume was reduced using n-butanol and the DNA was ethanol precipitated. The pellet was finally redissolved in TN buffer.
Reverse transcriptase treatment
In order to complete unfinished PCR products the fragments obtained from PCR mixtures were polished with AMV (avian myeloblastosis virus) reverse transcriptase. Approximately 1 µg PCR product was treated in an individual 50 µl reaction mixture containing 250 µM requisite nucleotides used in the PCR reaction together with 10 U enzyme in the commercially supplied buffer. After 4 h at 37_C, the samples were pooled and the volume reduced with n-butanol and then loaded onto a 6% non-denaturing polyacrylamide gel. The product band was excised from the gel and the DNA fragments were eluted using a unidirectional electroeluter (IBI).
Formation and 3′-labelling of hybrid DNA
To form the desired DNA hybrid 1-10 µg each of the two appropriate double-stranded DNA fragments were mixed in a TN-buffered reaction volume of 44 µl at pH 7. The liquid was overlaid with 60 µl mineral oil to prevent evaporation and heated to 94_C for 4 min, then slowly cooled to 37_C. In order to ensure proper reannealing the reaction was finally incubated for 30 min at 37_C. The mineral oil was removed, 2 µl [α-32 P]dCTP and 10 U AMV reverse transcriptase were added and the buffer adjusted to 50 mM Tris-HCl, pH 8.3, 50 mM KCl, 10 mM MgCl 2 , 10 mM dithiothreitol (DTT), 0.5 mM spermidine in a total volume of 60 µl. The mixture was incubated for 1 h at 37_C. When labelling the tyrT Watson strand a cold chase of dCTP was normally required after the labelling reaction to ensure the production of labelled fragments of uniform length. Accordingly, to these reaction mixtures were added 1 µl 100 mM cold dCTP and another 10 U AMV reverse transcriptase before incubating for a further 1 h at 37_C.
Purification of hybrid DNA
In order to separate the Crick strand-labelled DNA hybrid from the parental double-stranded DNA molecules, the 3′-labelled sample was loaded onto an 8% non-denaturing polyacrylamide gel and electrophoresed in TBE buffer at 200 V for 4 h. The hybrid band, located by exposing the gel to X-ray film as well as ethidium bromide staining, was excised and the DNA electroeluted. It was ethanol precipitated, washed three times with 70% (v/v) ice-cold ethanol, dried under a gentle stream of air and resuspended in TN buffer at 100 c.p.s./µl. For DNA molecules labelled on the Watson strand, the parental molecules could not be separated from the hybrids because the fragments were of equal length. However, since the labelling protocol leads to specific labelling of only one hybrid molecule, physical separation is not absolutely necessary. 
DNase I footprinting
These experiments were performed according to the method previously described (1, 5) . The DNA samples (2 µl, corresponding to 200 c.p.s) were incubated with 4 µl TN buffer containing the desired drug concentration. After 30 min at room temperature, 2 µl DNase I solution was added to each sample. The enzyme solution contained ∼0.01 U/ml DNase I in 20 mM NaCl, 2 mM MgCl 2 , 2 mM MnCl 2 , pH 8, and was prepared immediately before use from a stock solution. The exact dilution of the nuclease stock solution (7200 U/ml in 150 mM NaCl, 1 mM MgCl 2 ) was determined in preliminary calibration experiments so as to limit the extent of digestion to <30% of the starting material. This minimizes the incidence of multiple cuts in any one strand ('single-hit' kinetic conditions). After 3 min the nuclease reaction was stopped by freeze drying. The samples were then lyophilized and resuspended in 4 µl 80% formamide solution containing 0.1% bromophenol blue and 10 mM EDTA.
Gel electrophoresis and autoradiography
The products of DNA cleavage were separated on polyacrylamide gels under denaturing conditions (0.3 mm thick 8% acrylamide gels containing 8 M urea in TBE buffer). Immediately before loading the samples were heated to 90_C for 4 min and chilled on ice for 4 min. Electrophoresis was carried out at 60 W, 1600 V in TBE buffer for ∼2 h. After electrophoresis the gel was fixed in 10% (v/v) acetic acid and 10% (v/v) methanol for 15 min. It was then transferred to Whatman 3MM paper and dried under vacuum at 80_C, followed by exposure to a PhosphorImager screen and/or an X-ray film (Fuji R-X) for ∼48 h.
Quantitation by storage phosphorimaging
A Molecular Dynamics 425E PhosphorImager was used to collect the data from storage screens exposed to dried gels overnight at room temperature. Baseline-corrected scans were analysed by integrating all the densities between two selected boundaries using ImageQuant version 3.3 software. Each resolved band was assigned to a particular nucleotide of the tyrT fragment by comparing its position with Maxam-Gilbert sequencing standards (G+A tracks) (29) .
RESULTS
Synthesis of hybrid duplex DNA molecules
In order to footprint the binding sites of antibiotic molecules on duplex DNAs asymmetrically substituted with unnatural nucleotides in one or other of the complementary strands we devised a strategy based on the use of PCR primers which would result in the production of complementary strands of different lengths. The primers were designed so that after denaturing and annealing together the products from two separate PCR reactions, the desired hybrid duplex would be the only substrate with the correct configuration to permit 3′-end-labelling by reverse transcriptase. As the most suitable DNA sequence for a subsequent footprinting study we chose the tyrT fragment from Escherichia coli, which represents a portion of the tyrosine tRNA gene together with upstream control elements ( Fig. 2; 30) ; it offers a great variety of binding sites and has been extensively employed in previous footprinting experiments (1, 5) . First, we undertook a computer analysis of the tyrT DNA sequence, which revealed the absence of repeated sequences or inverted repeat sequences >7 nt long which could interfere with proper reannealing of the complementary single strands (31). Then we conducted exploratory tests to check that the proposed primers would be acceptable to various thermostable polymerases and to determine optimum conditions for incorporation of inosine-and DAP-containing nucleotides. Next we used PCR with various combinations of primers to make two tyrT DNA fragments of slightly different lengths which were mixed, denatured by heating and slowly cooled to allow reannealing of the complementary single strands. By this process not only are the parental PCR products reformed, but also hybrid molecules are created with strands originating from the two different PCR reactions. One of these two possible hybrid molecules should then be specifically 3′-labelled by AMV reverse transcriptase in the presence of a radioactively labelled nucleotide. By synthesizing the complementary strands of the hybrid molecules in two different PCR reactions we could unambiguously define the nucleotide content of the individual DNA strands. Thus we established an ideal protocol for synthesizing hybrid tyrT DNA molecules in which the 3′-labelled Crick strand contained natural nucleotides and the complementary Watson strand contained inosine and/or DAP substituted for the natural guanosine and adenine nucleotides. The labelled Crick strand was derived from a PCR setup with natural nucleotides and the Crick primer 3 and Watson primer 2 (see Fig. 2 ). The complementary Watson strand containing the base analogues was synthesized by using Crick primer 3 and Watson primer 1. The strict requirement for a 3′-hydroxyl group with a single-stranded template 5′-overhang ensured that only the hybrid molecule containing a natural Crick strand and an artificial Watson strand became labelled in the reverse transcriptase reaction. The other hybrid molecule containing an artificial Crick strand and a natural Watson strand, as well as the reformed original PCR molecules, did not offer a 3′-end with a single-stranded template and therefore were not labelled. In order to suppress possible non-specific labelling of incomplete strands we polished the initial PCR products using reverse transcriptase before heating and annealing to form the hybrid molecules. An added bonus of this protocol was that the difference in length between the hybrid and either of the parental molecules meant it could be physically separated from them on a neutral gel. Finally, for strict comparability all controls were performed using hybrid molecules prepared from PCR products synthesized with natural nucleotides in both strands. Figure 3 illustrates an experiment in which the effects of actinomycin and echinomycin on DNase I cutting of a hybrid containing inosine in the (unlabelled) Watson strand were compared. It is immediately apparent that neither antibiotic has much effect. The failure of echinomycin to produce footprints even at concentrations well above the saturation limit for purely aqueous solutions is not unexpected and accords perfectly with the findings reported in an earler publication from this laboratory, where binding to a short synthetic polynucleotide was examined (10) . Normally echinomycin would produce five or six strong footprints centred around the CpG steps on the Crick strand of tyrT DNA at a concentration of 1-2 µM, as verified in control experiments (not shown). Likewise, there is very little evidence of cleavage inhibition by actinomycin at concentrations far higher than those required to produce strong footprints around the GpC sequences of natural tyrT DNA (for an example compare the two left hand tracks in Fig. 6 ). Interestingly, in the actinomycin tracks of Figure 3 a faint footprint can still be discerned around position 100, which originates from a run of four G residues present in the Crick strand of the DNA hybrid molecule, synthesized with natural nucleotides, of course. The conclusions from Figure 3 are refreshingly clear-cut, namely that neither antibiotic binds to its cognate alternating pyrimidine-purine or purine-pyrimidine site if the 2-amino group is removed from one of the G residues at that site. The CpG·CpI step will not accept echinomycin and the GpC·IpC step will not accept actinomycin. This might be taken as evidence that both antibiotics need to be capable of forming four hydrogen bonds with their receptor, but the situation is not so simple, as we shall see.
Footprinting on DNA molecules asymmetrically substituted with inosine
Footprinting on DNA molecules substituted asymmetrically with DAP
Previous studies using PCR molecules substituted with DAP in both strands indicated that echinomycin and actinomycin bound preferentially to the DAP-containing sequences rather than to their canonical sites containing G·C base pairs (27) . To investigate this issue further and to determine the effect of placing single DAP residues at potential binding sites, we examined the binding of the ligands to tyrT DNA molecules asymmetrically substituted with DAP. With increasing echinomycin concentration we observed a general depression of DNase I cleavage starting at ∼0.5 µM, indicative of echinomycin binding to many sites, presumably including the canonical sites composed of CpG·CpG dinucleotide steps together with newly created sites containing DAP (Fig. 4) . In contrast, addition of actinomycin D produced two distinct regions of footprinting (Fig. 4) : one major area of DNase protection was observed between positions 54 and 75 and another region occurred around position 35. Quantitative analysis of all gel lanes using the phosphorimager enabled the construction of differential cleavage plots (Fig. 5 ), but they were of limited value for echinomycin because of the widespread protection against nuclease cutting. Nevertheless, it is possible to infer that for both antibiotics there does seem to be preferential binding to sites containing DAP residues. With echinomycin one can correlate most of the dips in the differential cleavage plots with sites close to TpG·CpD and TpA·TpD dinucleotide steps, although many of the excursions are barely significant. For actinomycin it is possible to state more confidently that DNase I protection lies predominantly at positions where GpT·DpC dinucleotide steps can be found and the canonical GpC·GpC steps do not seem well protected (Fig. 5) .
Footprinting on hybrid molecules containing both inosine and DAP in the same strand
If the confused pattern of footprinting seen with echinomycin on asymmetrically DAP-substituted DNA were due to the presence of 'normal' CpG·CpG sites as well as newly created binding sites containing DAP, the situation should be clarified by eliminating the former, which can of course be done by incorporating inosine. Footprinting experiments on this DNA in the presence of increasing concentrations of echinomycin still showed a general inhibition of DNase I cleavage (Fig. 6) . Phosphorimager analysis produced a set of differential cleavage plots which were virtually superimposible upon those obtained with asymmetric DAP substitution alone (see examples in Fig. 5) . Evidently, the rather enigmatic appearance of these plots cannot be attributed to residual interaction with the canonical GC-containing sites, but it still looks as if the preference for TpA·TpD and TpG·CpD sequences is less than decisive, even at the critically low concentration chosen for illustration in Figure 5 . Much the same conclusion applies to the data for actinomycin footprinting on double asymmetrically substituted DNA; the gels in Figure 6 are not a lot different from those in Figure 4 and a differential cleavage plot calculated from the 2 µM track, where clear footprinting is first evident, reveals two principal binding sites close to the GpT·DpC steps at positions 34 and 57 (Fig. 5) . The chief difference from the plot for DAP-substituted DNA lies in the relatively weak protection of three upstream GpT·DpC steps clustered between positions 62 and 69. However, since the same type of step at position 39 is not protected in either hybrid DNA, the simplest conclusion at this stage is that the presence of a GpT·DpC dinucleotide is necessary but not sufficient to compose a preferred binding site for actinomycin in these DNAs.
Footprinting on hybrid molecules containing inosine in both strands and DAP in one strand
While the results with asymmetrically inosine-substituted DNA presented in Figure 3 establish beyond reasonable doubt that a single guanine nucleotide present at the alternating pyrimidine-purine or purine-pyrimidine step is insufficient to afford a binding site for either antibiotic, it is more difficult to determine whether a single DAP nucleotide (which also bears a 2-amino group) might suffice.To address this question we needed to eliminate all guanine nucleotides from both strands and to incorporate DAP asymmetrically into one of them. This was best achieved by adopting a variation on the standard protocol such that footprinting was investigated on the Watson strand, which also contained DAP. To construct this hybrid DNA molecule we made one PCR product containing inosine instead of guanosine using Watson primer 1 and Crick primer 1 (see Fig. 2 ). The second PCR product, which would provide the 3′-labelled Watson strand for the desired hybrid, was made with inosine and DAP using Watson primer 1 and Crick primer 2. The polished PCR products were mixed, heated, annealed and labelled in the usual manner. The results of a footprinting experiment with echinomycin are shown in Figure 7 , where it is absolutely clear that the antibiotic binds very strongly and specifically at five sites, all centred round the TpD·TpA steps at positions 20-33 (composite), 60, 88, 110 and 126-136 (composite). Sharply defined footprints are already evident at an echinomycin concentration of only 1 µM and only the site at position 60 shows any sign of significant development as the drug concentration is raised 25-fold: the other footprints appear more or less fully formed at the lowest concentration tested. In other experiments (not shown) the footprints were detectable at sub-micromolar concentrations, just as they were with the DAP-substituted DNAs illustrated in Figures 4 and 6 .
It is equally certain that there is no interaction whatsoever between echinomycin and the CpD·TpI steps at positions 70, 81 and 118 in the hybrid DNA of Figure 7 . Moreover, when the same experiments were performed using actinomycin at concentrations between 1 and 40 µM no footprints were observed, save a possible weakening of bands around position 128 at a run of five consecutive DAP residues. The conclusion is clear, that actinomycin will not bind to either of the steps DpC·IpT or DpT·ApT which offer only a single purine 2-amino group in the minor groove of the helix.
DISCUSSION
The purine 2-amino group is confirmed as a crucial requirement for binding of actinomycin D and echinomycin in the minor groove, as expected. Moreover, the present results show conclusively that for specific binding of actinomycin to DNA two purine 2-amino groups are necessary, i.e. both base pairs at the purine (3′-5′) pyrimidine recognition step must contain either guanine or DAP. None of the four possible dinucleotide pair arrangements containing only a single G or DAP residue will support binding of the antibiotic (Table 1 ) and neither will the IpC·IpC, ApT·ApT or IpT·ApC steps which lack a purine 2-amino group altogether. The only remaining oddity in our results with actinomycin concerns its apparent predilection for binding to a 'mixed' DpC·GpT step when confronted with a choice between that and the canonical GpC·GpC step, though the preference may not be large (Figs 4 and 5) . The finding is not entirely unexpected, given our previous observation that actinomycin certainly prefers the DpT·DpT site to the GpC·GpC site in fully DAP-substituted DNA (2,27), but it remains unexplained.
The situation with echinomycin is tantalisingly different. The present results confirm in a more compelling fashion the previous finding that echinomycin will not bind to sites containing one or two I·C base pairs (10) and add the new information that it marginally prefers the 'mixed' CpD·TpG step to its canonical CpG·CpG site, just as it preferred the site composed of two DAP·T pairs in a previous study (27) . That much is parallel with the actinomycin results, but the big difference we now find is that echinomycin binds very well indeed to the TpD·TpA site, which offers only a single purine 2-amino group on the DAP residue. Not only that, but if the DAP·T base pair is juxtaposed with an I·C pair instead of an A·T pair, the resulting CpD·TpI step will not bind echinomycin (Table 1 ). These observations point to a substantial difference between the mechanisms of DNA site recognition by the two peptide antibiotics, which perhaps implies less stringent sequence discrimination on the part of echinomycin. Such is quite likely the case, for, notwithstanding its exemplary nucleotide sequence specificity in footprinting experiments, we recall that echinomycin will bind, albeit rather weakly, to poly(dA·dT) (32) . At all events, its capacity to bind tightly to sites containing the TpD·TpA step, which present only a single 2-amino group, is entirely consistent with the findings of X-ray and NMR work on echinomycinoligonucleotide complexes (7-9), though we have never found evidence of binding to the naturally occurring TpG·CpA step in footprinting experiments, including that illustrated in Figure 3 ( Table 1) . Table 1 . Summary of dinucleotide steps arranged purine-(3′-5′)-pyrimidine (top panel) or pyrimidine-(3′-5′)-purine (bottom panel) which can or cannot form an essential part of binding sites for antibiotics All possible combinations of G·C, A·T, I·C and D·T base pairs which offer at least one purine 2-amino group in the minor groove are shown, with the competent base highlighted in bold. The three steps which lack any 2-amino group (combinations of A·T and I·C pairs) do not bind either antibiotic and are omitted. Permissive steps are indicated by ; non-permissive steps by ".
There remains the intriguing question as to why echinomycin should so decisively eschew the CpD·TpI step, which equally well presents the favoured 2-amino group attached to a DAP residue. There must be something about the adjacent I·C pair which positively interferes with antibiotic binding, something not held in common with an A·T pair. Indeed, it may be regarded as suspicious that no steps containing an I·C base pair in the requisite orientation ever seem to form part of a binding site for echinomycin or actinomycin (Table 1) . Maybe the I·C base pair is not a valid model for a G·C pair which simply lacks the hydrogen bonding capability of the latter and maybe the effect of incorporating inosine into DNA has significant secondary consequences beyond the loss of a hydrogen bond donor in the minor groove. There is already evidence that inosine can affect the curvature and/or flexibility of DNA (see 33 for references) and it has been suggested that the dipole moment of an I·C pair may be particularly unfavourable for intercalative stacking interactions, whereas that of a DAP·T pair may be propitious (34) . The idea that stacking interactions could play as important a part as hydrogen bonding in determining the molecular basis of sequence recognition by antibiotics is attractive and has been adumbrated over the years by many authors (4, 15, 16, 35) . It is open to investigation using the techniques developed for this work, as indeed are other questions relating to the mechanisms by which ligands, great and small, natural and artificial, recognize their target sites in DNA.
